New Report: Critically Low Lung Cancer Screening Rates Reveal Opportunity to Save More Lives
American Lung Association’s report examines toll of lung cancer state-by-state, underscores urgent need for more people to be screened
November 15, 2022
Breath Diagnostics, Mayo Clinic Laboratories Announce Collaboration to Develop New Diagnostic Test That Detects Lung Cancer Using Patients’ Exhaled Breath
Breath Diagnostics, Inc. and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
1 : OneBreath™ is under development and has not yet been reviewed, evaluated, or approved by the U.S. Food and Drug Administration (FDA), or any other health authority or regulatory body worldwide. As such, OneBreath™ should not be considered available for use.
2 : The data, metrics, and statistics presented on this website, along with any other related communication materials, reflect preliminary research findings and clinical testing outcomes for the OneBreath™ product currently under development.Please note, these preliminary findings are not intended to serve as conclusive evidence of the safety, efficacy, or performance of OneBreath™, nor should they be interpreted as such.